MANDT |
Client |
MANDT |
|
CLNT |
|
3 |
0 |
|
GCN_SEQNO |
SMX: FDB GCN - Clinical Formulation ID ( (Stable ID) |
ZFDB_GCN_SEQNO |
|
CHAR |
|
6 |
0 |
|
HIC3 |
SMX: FDB Hier. Specific Therapeutic Class Code (Stable ID) |
ZFDB_HIC3 |
|
CHAR |
|
3 |
0 |
|
HICL_SEQNO |
SMX: FDB Ingredient List Identifier |
ZFDB_HICL_SEQNO |
ZFDB_RHICLSQ1
|
CHAR |
|
6 |
0 |
|
GCDF |
SMX: FDB Dosage Form Code (2 character) |
ZFDB_GCDF |
ZFDB_RDOSED2
|
CHAR |
|
2 |
0 |
|
GCRT |
SMX: FDB Route of Administration Code |
ZFDB_GCRT |
ZFDB_RROUTED3
|
CHAR |
|
1 |
0 |
|
STR |
SMX: FDB Drug Strength Description |
ZFDB_STR |
|
CHAR |
|
10 |
0 |
|
GTC |
SMX: FDB Therapeutic Class Code, Generic |
ZFDB_GTC |
|
CHAR |
|
2 |
0 |
Possible values
02 |
ANALGESICS |
03 |
ANALGESIC AND ANTIHISTAMINE COMBINATION |
05 |
ANESTHETICS |
08 |
ANTI-OBESTITY DRUGS |
09 |
ANTIDOTES |
11 |
ANTIARTHRITICS |
14 |
ANTIASTHMATICS |
17 |
ANTIHISTAMINES |
18 |
ANTIHISTAMINE AND DECONGESTANT COMBINATION |
20 |
ANTIINFECTIVES |
23 |
ANTIINFECTIVES/MISCELLANEOUS |
26 |
ANTINEOPLASTICS |
29 |
ANTIPARKINSON DRUGS |
32 |
AUTONOMIC DRUGS |
35 |
BLOOD |
38 |
CARDIAC DRUGS |
41 |
CARDIOVASCULAR |
44 |
CNS DRUGS |
47 |
CONTRACEPTIVES |
50 |
COUGH/COLD PREPARATIONS |
53 |
DIAGNOSTIC |
56 |
DIURETICS |
59 |
ELECT/CALORIC/H2O |
62 |
EENT PREPS |
65 |
GASTROINTESTINAL |
68 |
HORMONES |
71 |
HYPOGLYCEMICS |
72 |
IMMUNOSUPPRESANT |
74 |
MISCELLANEOUS MEDICAL SUPPLIES, DEVICES, NON-DRUG |
77 |
MUSCLE RELAXANTS |
80 |
PSYCHOTHERAPEUTIC DRUGS |
83 |
SEDATIVE/HYPNOTICS |
86 |
SKIN PREPS |
89 |
THYROID PREPS |
92 |
BIOLOGICALS |
94 |
PRE-NATAL VITAMINS |
95 |
VITAMINS |
97 |
SMOKING DETERRENTS |
98 |
HERBALS |
99 |
UNCLASSIFIED DRUG PRODUCTS |
|
TC |
SMX: FDB Therapeutic Class Code, , Standard |
ZFDB_TC |
ZFDB_RTCD0
|
CHAR |
|
2 |
0 |
|
DCC |
SMX: FDB Drug Category Code |
ZFDB_DCC |
|
CHAR |
|
1 |
0 |
Possible values
0 |
UNSPECIFIED |
1 |
DRUGS TO TREAT IMPOTENCY |
2 |
GROWTH HORMONE, GHRH, AND RELATED AGENTS |
3 |
NARCOLEPSY AND SLEEP DISORDER THERAPY |
A |
ANTI-ANXIETY AGENTS |
B |
FERTILITY AGENTS |
C |
CONTRACEPTIVES, ORAL |
D |
DIAGNOSTICS |
E |
FLUORIDE PREPARATIONS (EXCL.VIT.COMB.) |
F |
ANTIOBESITY DRUGS |
G |
ANTACIDS |
H |
HEMATINICS |
I |
INSULINS |
J |
SMOKING DETERRENTS |
K |
AIDS RELATED |
L |
LAXATIVES |
M |
REUSABLE NEEDLES (ALL) |
N |
DISPOSABLE NEEDLES (ALL) |
O |
REUS.SYRINGES W/WO NEEDLES (NON-INSULIN) |
P |
DISP.SYRINGES W/WO NEEDLES (NON-INSULIN) |
Q |
REUSABLE SYRINGES W/WO NEEDLES (INSULIN) |
R |
DISP.SYRINGES W/WO NEEDLES (INSULIN) |
S |
DIABETIC SUPPLIES, MISC. |
T |
CONTRACEPTIVES, TOPICAL |
U |
NON-REIMBURSABLE COSMETIC INDICATIONS |
V |
VITAMINS, COMMONLY EXCLUDED |
W |
CONTRACEPTIVES, SYSTEMIC, NON-ORAL |
Y |
OSTOMY SUPPLIES |
Z |
ATTENTION DEFICIT DISORDER/NARCOLEPSY |
|
GCNSEQ_GI |
SMX: FDB GCN_SEQNO-Level Multi-Source/Single Source Ind. |
ZFDB_GCNSEQ_GI |
|
CHAR |
|
1 |
0 |
Possible values
0 |
Unassigned |
1 |
Multiple source |
2 |
Single source |
|
GENDER |
SMX: FDB Gender-Specific Drug Indicator |
ZFDB_GENDER |
|
CHAR |
|
1 |
0 |
Possible values
0 |
Neutral; not gender specific (default) |
1 |
Used exclusively in males |
2 |
Most likely used in males |
3 |
Used exclusively in females |
4 |
Most likely used in females |
|
HIC3_SEQN |
SMX: FDB Hierarchical Specific Therapeutic Class Code Seq. # |
ZFDB_HIC3_SEQN |
|
CHAR |
|
6 |
0 |
|
STR60 |
SMX: FDB Drug Strength Description - 60 |
ZFDB_STR60 |
ZFDB_RSTR1
|
CHAR |
|
60 |
0 |
|